Medtronic PLC (MDT)
Working capital turnover
| Apr 30, 2025 | Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 33,537,000 | 32,364,000 | 32,961,000 | 31,227,000 | 31,528,000 |
| Total current assets | US$ in thousands | 23,814,000 | 21,935,000 | 21,935,000 | 21,675,000 | 21,675,000 |
| Total current liabilities | US$ in thousands | 12,879,000 | 10,789,000 | 10,789,000 | 9,051,000 | 9,051,000 |
| Working capital turnover | 3.07 | 2.90 | 2.96 | 2.47 | 2.50 |
April 30, 2025 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $33,537,000K ÷ ($23,814,000K – $12,879,000K)
= 3.07
The working capital turnover for Medtronic PLC has been showing a positive trend over the years, indicating efficiency in utilizing its working capital to generate sales. The ratio has increased from 2.50 in April 28, 2023, to 3.07 in April 30, 2025. This improvement suggests that the company is able to efficiently manage its current assets and liabilities to support its operations and sales growth. A higher working capital turnover ratio is generally favorable as it indicates that the company is able to generate more revenue with less investment in working capital, which can improve overall financial performance and liquidity.
Peer comparison
Apr 30, 2025